Literature DB >> 1761657

Hormonal and histological evaluation of the luteal phase after combined GnRH-agonist/gonadotrophin treatment for superovulation and luteal phase support in in-vitro fertilization.

J Balasch1, I Jové, M Márquez, J A Vanrell.   

Abstract

A hormonal and histological study of the luteal phase was performed in 21 stimulated in-vitro fertilization (IVF) patients not undergoing embryo transfer. Ovarian stimulation was carried out with gonadotrophins [follicle stimulating hormone (FSH) + human menopausal gonadotrophin (HMG)] under pituitary suppression with buserelin. Ovulation was induced with 5000 IU human chorionic gonadotrophin (HCG) and additional doses of 5000, 2500 and 2500 IU were given on the day of follicular aspiration, and 2 and 5 days later respectively, to support the luteal phase. Supraphysiological levels of oestradiol (E2) and progesterone in plasma were found in the midluteal phase of all women, while prolactin was in the normal range. An endometrial biopsy taken in the late luteal phase was normal in 90.5% (19/21) of patients, most of them (15/19, 79%) having E2 greater than 1500 pg/ml on the day of HCG. Conversely, both patients with defective endometrial biopsies had E2 levels less than 1500 pg/ml.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761657     DOI: 10.1093/oxfordjournals.humrep.a137458

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Influence of midluteal serum prolactin on outcome of pregnancy after IVF-ET: a preliminary study.

Authors:  T Ozaki; K Takahashi; H Kurioka; K Miyazaki
Journal:  J Assist Reprod Genet       Date:  2001-07       Impact factor: 3.412

2.  Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

Authors:  E Araujo; L Bernardini; J L Frederick; R H Asch; J P Balmaceda
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.